TFAP4 inhibits differentiation of MYCN-amplified neuroblastoma

被引：0
|
作者：
Zhang, Shuobo [1 ]
Lopez, Gonzalo [1 ]
Yu, Jiyang [2 ]
Silva, Jose [3 ]
Kadenhe-Chiweshe, Angela [1 ]
Califano, Andrea [1 ]
Yamashiro, Darrell [1 ]
机构：
[1] Columbia Univ, New York, NY USA
[2] Pfizer, New York, NY USA
[3] Mt Sainai Med Sch, New York, NY USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-2083
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2083
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Transcriptional Repression of SKP2 Is Impaired in MYCN-Amplified Neuroblastoma
    Muth, Daniel
    Ghazaryan, Seda
    Eckerle, Isabella
    Beckett, Emily
    Poehler, Christina
    Batzler, Julia
    Beisel, Claudia
    Gogolin, Sina
    Fischer, Matthias
    Henrich, Kai-Oliver
    Ehemann, Volker
    Gillespie, Paul
    Schwab, Manfred
    Westermann, Frank
    CANCER RESEARCH, 2010, 70 (09) : 3791 - 3802
  • [42] RETRACTION: Targeting MYCN IRES in MYCN-amplified Neuroblastoma With Mir-375 Inhibits Tumor Growth and Sensitizes Tumor Cells to Radiation
    Zhang, H.
    Liu, T.
    Yi, S.
    Gu, L.
    Zhou, M.
    MOLECULAR ONCOLOGY, 2025, 19 (01) : 261 - 261
  • [43] Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma
    Boboila, Shuobo
    Lopez, Gonzalo
    Yu, Jiyang
    Banerjee, Debarshi
    Kadenhe-Chiweshe, Angela
    Connolly, Eileen P.
    Kandel, Jessica J.
    Rajbhandari, Presha
    Silva, Jose M.
    Califano, Andrea
    Yamashiro, Darrell J.
    ONCOGENE, 2018, 37 (40) : 5451 - 5465
  • [44] Imipridones show pre-clinical efficacy in MYCN-amplified and MYCN non-amplified neuroblastoma cell lines
    Triboulet, Robinson
    Sadykov, Khikmet
    Johnson, Jessica L.
    Snyder, Andrew R.
    Knutson, Sarah K.
    Kumar, Pavan
    Mayo, Christopher B.
    Hawley, Dillon
    Madanjian, Andrew
    Stein, Ross L.
    Wilson, David M.
    Harvey, Darren M.
    Ghosh, Shomir
    Campbell, Robert M.
    CANCER RESEARCH, 2022, 82 (12)
  • [45] Lysis of MYCN-amplified neuroblastoma cells by MYCN peptide-specific cytotoxic T lymphocytes
    Sarkar, AK
    Nuchtern, JG
    CANCER RESEARCH, 2000, 60 (07) : 1908 - 1913
  • [46] Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma
    Shuobo Boboila
    Gonzalo Lopez
    Jiyang Yu
    Debarshi Banerjee
    Angela Kadenhe-Chiweshe
    Eileen P. Connolly
    Jessica J. Kandel
    Presha Rajbhandari
    Jose M. Silva
    Andrea Califano
    Darrell J. Yamashiro
    Oncogene, 2018, 37 : 5451 - 5465
  • [47] Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma
    Henriksen, Jorn R.
    Haug, Bjorn Helge
    Buechner, Jochen
    Tomte, Ellen
    Lokke, Cecilie
    Flaegstad, Trond
    Einvik, Christer
    BMC DEVELOPMENTAL BIOLOGY, 2011, 11
  • [48] The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma In Vivo
    Faisal, Amir
    Vaughan, Lynsey
    Bavetsias, Vassilios
    Sun, Chongbo
    Atrash, Butrus
    Avery, Sian
    Jamin, Yann
    Robinson, Simon P.
    Workman, Paul
    Blagg, Julian
    Raynaud, Florence I.
    Eccles, Suzanne A.
    Chesler, Louis
    Linardopoulos, Spiros
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (11) : 2115 - 2123
  • [49] Aurora-A stabilizes N-myc protein in MYCN-amplified neuroblastoma
    Berwanger, B.
    Otto, T.
    Horn, S.
    Schuettstrumpf, L.
    Kenney, A.
    Eilers, U.
    Eggert, A.
    Christiansen, H.
    Eilers, M.
    KLINISCHE PADIATRIE, 2008, 220 (03): : 198 - 198
  • [50] EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma
    Durbin, Adam D.
    Wang, Tingjian
    Wimalasena, Virangika K.
    Zimmerman, Mark W.
    Li, Deyao
    Dharia, Neekesh, V
    Mariani, Luca
    Shendy, Noha A. M.
    Nance, Stephanie
    Patel, Anand G.
    Shao, Ying
    Mundada, Maya
    Maxham, Lily
    Park, Paul M. C.
    Sigua, Logan H.
    Morita, Ken
    Conway, Amy Saur
    Robichaud, Amanda L.
    Perez-Atayde, Antonio R.
    Bikowitz, Melissa J.
    Quinn, Taylor R.
    Wiest, Olaf
    Easton, John
    Schonbrunn, Ernst
    Bulyk, Martha L.
    Abraham, Brian J.
    Stegmaier, Kimberly
    Look, A. Thomas
    Qi, Jun
    CANCER DISCOVERY, 2022, 12 (03) : 730 - 751
12345